Chemical Structure (Zynlonta 01)
Zynlonta Injection, Powder, Lyophilized, For Solution
Product Images NDC 79952-110
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zynlonta (NDC 79952-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Adc Therapeutics America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (10 mg Vial Carton)
Zynlonta is a hazardous agent available in vials containing 10mg of loncastuximab. Prior to administration, the vial should be reconstituted and diluted with 5% dextrose injection and stored at 2°C to 8°C. The reconstituted solution with pH approximately 6.0 should not be exposed to direct sunlight, shaken or frozen. No preservative and standard of potency are used. The drug is for intravenous infusion only and the package should be discarded if any unused portion remains.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
